Despite previous excitement around a potential link between GLP-1 drugs and a reduced risk of cancer, new research suggests the popular medications “probably have little or no effect” on a person’s ...

A New York Times health reporter explains what makes a good study, and how she knows which papers merit an article. Credit...Ricardo Tomás Supported by By Dani Blum New health research publishes every ...

Recruiting and retaining study subjects remains a significant challenge for medical device companies that are innovating and sponsoring clinical trials, particularly when designing studies that ...

A drug taken by millions of people to control diabetes may do more than lower blood sugar. Research suggests metformin has anti-inflammatory effects that could help protect against common age-related ...

ChatGPT launched in late 2022. By the middle of 2025, the platform was fielding 18 billion messages per week from 700 million users. Needless to say, that’s a big change. Now, a new study has dug into ...